THE NEW CITY MEDICAL GROUP
TATHAM STREET, SUNDERLAND
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 42 | 45 | 93.3% | |
| HF 4 | 2011 | 36 | 44 | 81.8% | |
| HF 4 | 2012 | 39 | 44 | 88.6% | |
| HF 4 | 2013 | 36 | 42 | 85.7% | |
| HF004 | 2014 | 42 | 44 | 95.5% | |
| HF004 | 2015 | 34 | 38 | 89.5% | |
| HF004 | 2016 | 40 | 45 | 88.9% | |
| HF004 | 2017 | 39 | 42 | 92.9% | |
| HF004 | 2018 | 36 | 39 | 92.3% | |
| HF004 | 2019 | 37 | 37 | 100.0% | |
| HF004 | 2020 | 31 | 33 | 93.9% | |
| HF006 | 2021 | 32 | 35 | 91.4% | |
| HF006 | 2022 | 32 | 35 | 91.4% | |
| HF006 | 2023 | 37 | 41 | 90.2% |
